Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Aug 2020
Historique:
received: 30 07 2020
revised: 14 08 2020
accepted: 15 08 2020
entrez: 23 8 2020
pubmed: 23 8 2020
medline: 17 2 2021
Statut: epublish

Résumé

Seminal plasma (SP) contains a unique concentration of miRNA, mostly contained in small extracellular vesicles (sEVs) such as exosomes, some of which could be clinically useful for diagnosis and/or prognosis of urogenital diseases such as prostate cancer (PCa). We optimized several exosome-EV isolation technologies for their use in semen, evaluating EV purifying effectiveness and impact on the downstream analysis of miRNAs against results from the standard ultracentrifugation (UC) method to implement the use of SP sEV_miRNAs as noninvasive biomarkers for PCa. Our results evidenced that commercial kits designed to isolate exosomes/EVs from blood or urine are mostly applicable to SP, but showed quantitative and qualitative variability between them.

Identifiants

pubmed: 32824915
pii: ijms21175949
doi: 10.3390/ijms21175949
pmc: PMC7504614
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
MicroRNAs 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI15/00153; DTS18/00101
Organisme : Generalitat de Catalunya
ID : 2017SGR191

Références

Pharmacol Ther. 2017 Jun;174:63-78
pubmed: 28202367
Cancers (Basel). 2019 Dec 12;11(12):
pubmed: 31842290
Clin Chem. 2010 Nov;56(11):1733-41
pubmed: 20847327
Mol Cancer. 2017 Apr 14;16(1):80
pubmed: 28410618
Mol Immunol. 2012 Apr;50(4):278-86
pubmed: 22424315
J Extracell Vesicles. 2015 Dec 23;4:29509
pubmed: 26700615
Cytometry A. 2018 Feb;93(2):177-179
pubmed: 28700124
Hum Reprod. 2018 Jun 1;33(6):1087-1098
pubmed: 29635626
Int J Mol Med. 2017 Sep;40(3):834-844
pubmed: 28737826
J Extracell Vesicles. 2013 Sep 12;2:
pubmed: 24223256
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
Am J Clin Pathol. 1970 Sep;54(3):448-50
pubmed: 5459731
J Extracell Vesicles. 2015 Jul 17;4:27031
pubmed: 26194179
Prostate. 1997 Feb 1;30(2):98-106
pubmed: 9051148
Bio Protoc. 2017 Apr 5;7(7):
pubmed: 28660234
Sci Rep. 2019 Sep 24;9(1):13772
pubmed: 31551516
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Nat Rev Urol. 2014 May;11(5):278-88
pubmed: 24709963
Clin Biochem. 2014 Jan;47(1-2):135-8
pubmed: 24183884
PLoS One. 2012;7(4):e34566
pubmed: 22506029
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Thromb Res. 2017 Jun;154:96-105
pubmed: 28460288
Nucleic Acids Res. 2014 Jun;42(11):7290-304
pubmed: 24838567
Int J Mol Sci. 2016 Oct 26;17(11):
pubmed: 27792187
PLoS One. 2017 Jan 23;12(1):e0170628
pubmed: 28114422

Auteurs

Marina Mercadal (M)

Human Molecular Genetics Group-Bellvitge Biomedical Research Institute (IDIBELL), 08908 Hospitalet de Llobregat, Barcelona, Spain.

Carolina Herrero (C)

Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.

Olga López-Rodrigo (O)

Laboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, 08025 Barcelona, Spain.

Manel Castells (M)

Urology Service, Bellvitge University Hospital-ICS, 08908 Hospitalet de Llobregat, Barcelona, Spain.

Alexandre de la Fuente (A)

NASASBIOTECH S.L., Santiago de Compostela Hospital (CHUS), 15706 Santiago de Compostela, Spain.

Francesc Vigués (F)

Urology Service, Bellvitge University Hospital-ICS, 08908 Hospitalet de Llobregat, Barcelona, Spain.

Lluís Bassas (L)

Laboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, 08025 Barcelona, Spain.

Sara Larriba (S)

Human Molecular Genetics Group-Bellvitge Biomedical Research Institute (IDIBELL), 08908 Hospitalet de Llobregat, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH